Preventing fake medicines from reaching patients

Boyds’ Director of Regulatory Affairs, Julie Warner, has co-edited an article in the October issue of the TOPRA journal, Regulatory Rapporteur, which focuses on falsified medicines. The following article was published in Regulatory Rapporteur, Volume 16, No 10, October 2019. Preventing fake medicines from reaching patients By Julie Warner, Director Regulatory Affairs, Alan Boyd Consultants, […]